Saturday, January 31, 2026

NVIDIA Takes a Breather as Blackwell Chip Demand Holds Strong

NVIDIA's stock dipped slightly, but demand for its Blackwell chip remains strong, indicating healthy market conditions.

North Korea To Resume Rason Tourism Suspended For Three Weeks… “Official Announcement Coming Soon”

North Korea's Rason region tourism may resume soon, following a brief suspension, as signs of reopening emerge amid COVID-19 concerns.

New Zealand’s P-8A Poseidon Uncovers Illicit North Korean Shipments

On June 12, Voice of America (VOA)...

Tag: biosimilar

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.